our mission over cherry blossoms

The Georgetown University Memory Disorders Program is dedicated to providing state-of-the-art clinical services for individuals affected by Alzheimer's disease and related disorders and to conducting research aimed at improving treatment options for Alzheimer's disease.
Research Studies

Here are our research studies that are currently recruiting patients. Check out our Research section for more information on how to participate in our clinical trials.

Title Sponsor
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil (CONCERT) Medivation
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer's Disease Baxter/ADCS
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease Elan Pharmaceuticals
A Study of V950 in People With Alzheimer's Disease Merck
Study Evaluating ACC-001 in Mild to Moderate Alzheimer's Disease Subjects Wyeth

We will soon be recruiting patients for the following study.

Title Sponsor
Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease Ceregene/ADCS
News feed icon

2009 Alzheimer's Association Memory Walk - 2009-09-11

For the second year in a row, the Memory Disorders Program will field a team to participate in the Alzheimer's Association Memory Walk, scheduled to t ... read more

Third Annual Patient Appreciation Lunch on 11/7/09 - 2009-09-11

Third Annual Patient Appreciation LunchWho: Patients, research participants, and families are all welcome to attend. The current program director, D ... read more

National Alzheimer's Gala - 2009-07-31

Memory Disorders Program research participant Robert Blackwell with Terrell Owens, professional football player for the NFL, at the National Gala bene ... read more

Visit our News section for more updates. Or, follow our news feed feed icon (RSS) to keep up-to-date!